TrueWealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-300
| Closed | -$214K | – | 233 |
|
|
2024
Q4 | $214K | Hold |
300
| – | – | 0.07% | 211 |
|
|
2024
Q3 | $315K | Hold |
300
| – | – | 0.11% | 169 |
|
|
2024
Q2 | $315K | Hold |
300
| – | – | 0.12% | 144 |
|
|
2024
Q1 | $289K | Hold |
300
| – | – | 0.11% | 156 |
|
|
2023
Q4 | $263K | Hold |
300
| – | – | 0.1% | 156 |
|
|
2023
Q3 | $247K | Hold |
300
| – | – | 0.1% | 157 |
|
|
2023
Q2 | $216K | Hold |
300
| – | – | 0.09% | 175 |
|
|
2023
Q1 | $247K | Hold |
300
| – | – | 0.1% | 158 |
|
|
2022
Q4 | $216K | Hold |
300
| – | – | 0.09% | 169 |
|
|
2022
Q3 | $207K | Buy |
+300
| New | +$207K | 0.1% | 155 |
|